Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/18/26 18:45 | 6/17/26 | MLTX | Health | Drug | Pharmaceutical Preparations | Bodenstedt Matthias | O | CFO | 4 | S.m | -2,336 | 19.19 | 0 | -122 | 1,189 | D | ||||||||||||||||
6/17/26 18:15 | 6/15/26 | MLTX | Health | Drug | Pharmaceutical Preparations | Reich Kristian | O | Chief Sc | 2 | S.m | -5,863 | 16.61 | 0 | -353 | 2,975 | I | ||||||||||||||||
4/14/26 17:55 | 4/10/26 | MLTX | Health | Drug | Pharmaceutical Preparations | Santos Da Silva Jorge | DO | CEO | 2 | S.m | -5,727 | 16.36 | 0 | -350 | 2,925 | D | ||||||||||||||||
4/2/26 16:48 | 3/31/26 | MLTX | Financ | InvAdv | Investment Advice | Bvf Partners L P/Il | CA | DT | 1 | S.d | -62,963 | 16.79 | 0 | -3,750 | 1,039 | D | ||||||||||||||||
10/1/25 17:22 | 9/29/25 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | H | Former 1 | 1 | S.m | -46,868 | 7.21 | 0 | -6,500 | 1,994 | I | |||||||||||||||
7/7/25 16:03 | 7/3/25 | MLTX | Health | Drug | Pharmaceutical Preparations | Moukheibir Catherine | V8 | D | 1 | S.d | -1,147 | 48.79 | 0 | -24 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |